Neoadjuvant chemotherapy for stage III and IV epithelial ovarian cancer: A comparative study.

被引：0
|
作者：
Loizzi, V
Cormio, G
Di Vagno, G
Resta, L
Cazzolla, A
Di Gilio, A
Cuccovillo, A
Selvaggi, L
机构：
[1] Univ Bari, Dept Ob Gyn, Bari, Italy
[2] Univ Bari, Dept Pathol, Bari, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5117
引用
收藏
页码：478S / 478S
页数：1
相关论文
共 50 条
  • [1] Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer
    Luo, Yanlin
    Lee, Maria
    Kim, Hee Seung
    Chung, Hyun Hoon
    Song, Yong Sang
    MEDICINE, 2016, 95 (36)
  • [2] Neoadjuvant chemotherapy in advanced stage epithelial ovarian cancer
    Kartsiounis, Christos
    Mitsakis, Ioannis
    Boutis, Anastasios
    Triantafillidis, Efstathios
    Evangelinos, Dimitrios
    Andreadis, Charalambos
    Kellartzis, Argirios
    ANNALS OF ONCOLOGY, 2006, 17 : 175 - 175
  • [3] NEOADJUVANT CHEMOTHERAPY VERSUS PRIMARY DEBULKING SURGERY IN FIGO STAGE III AND IV EPITHELIAL OVARIAN, TUBAL OR PERITONEAL CANCER
    Tzanis, A.
    Iavazzo, C. R.
    Hadjivasilis, A.
    Tsouvali, H.
    Antoniou, G.
    Antoniou, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A296 - A296
  • [4] Neoadjuvant chemotherapy versus primary surgery in patients with stage III/IV endometrial cancer: A National Cancer Database study.
    Cummings, Mackenzie
    Nicolais, Olivia
    Banks, Joshua
    Keith, Scott W.
    Burton, Elizabeth
    Shahin, Mark S.
    Sorosky, Joel I.
    Edelson, Mitchell
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Demethylation of the MCJ gene in stage III/IV epithelial ovarian cancer and response to chemotherapy
    Strathdee, G
    Vass, JK
    Oien, KA
    Siddiqui, N
    Curto-Garcia, J
    Brown, R
    GYNECOLOGIC ONCOLOGY, 2005, 97 (03) : 898 - 903
  • [6] Neoadjuvant chemotherapy for FIGO stage III or IV ovarian cancer: Survival benefit and prognostic factors
    Shibata, K
    Kikkawa, F
    Mika, M
    Suzuki, Y
    Kajiyama, H
    Ino, K
    Mizutani, S
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 (05) : 587 - 592
  • [7] Neoadjuvant chemotherapy or primary surgery for stage III/IV ovarian cancer: contribution of diagnostic laparoscopy
    Jean-Luc Brun
    Roman Rouzier
    Frédéric Selle
    Sidney Houry
    Serge Uzan
    Emile Daraï
    BMC Cancer, 9
  • [8] Neoadjuvant chemotherapy or primary surgery for stage III/IV ovarian cancer: contribution of diagnostic laparoscopy
    Brun, Jean-Luc
    Rouzier, Roman
    Selle, Frederic
    Houry, Sidney
    Uzan, Serge
    Darai, Emile
    BMC CANCER, 2009, 9
  • [9] Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
    Vergote, Ignace
    Trope, Claes G.
    Amant, Frederic
    Kristensen, Gunnar B.
    Ehlen, Tom
    Johnson, Nick
    Verheijen, Rene H. M.
    van der Burg, Maria E. L.
    Lacave, Angel J.
    Panici, Pierluigi Benedetti
    Kenter, Gemma G.
    Casado, Antonio
    Mendiola, Cesar
    Coens, Corneel
    Verleye, Leen
    Stuart, Gavin C. E.
    Pecorelli, Sergio
    Reed, Nick S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (10): : 943 - 953
  • [10] To compare the optimal cytoreduction rate in advanced epithelial ovarian cancer stage III/IV after 3 versus 6 cycles of neoadjuvant chemotherapy
    Kumari, Archana
    Thakur, Monika
    Saha, S. C.
    Suri, Vanita
    Prasad, G. R. V.
    Patel, Firuza D.
    Radhika, S.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 41 (04) : 616 - 620
12345